Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of investigational allergology & clinical immunology 2021-04, Vol.31 (2), p.180-181
Hauptverfasser:	Rojas-Pérez-Ezquerra, P, Crespo Quirós, J, Tornero Molina, P, Baeza Ochoa de Ocáriz, M L, Zubeldia Ortuño, J M
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Adult Aged Anaphylaxis - diagnosis Anaphylaxis - etiology BNT162 Vaccine COVID-19 - prevention & control COVID-19 Vaccines - adverse effects Drug Hypersensitivity - diagnosis Drug Hypersensitivity - etiology Excipients - adverse effects Female Humans Male Middle Aged mRNA Vaccines SARS-CoV-2 - immunology Skin Tests Surveys and Questionnaires Vaccines, Synthetic - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!